Front > Comment


Gali Weinreb  illustration: Gil Gibli Israeli biotechs - the horrible truth

American industry commentator Adam Feuerstein shouted what many whisper - but the horror isn't just one way. 

Norman Bailey  illustration: Gil Gibli On Iran, follow Reagan's example

Planning and forceful implementation can bring down the ayatollahs as it did the Soviet bloc.

Dror Marmor  illustration: Gil Gibli Fake news: Trump Station at Western Wall

Transport minister Yisrael Katz is wasting NIS 10 million designing a plan for a Jerusalem station that will never be built.

Norman Bailey  illustration: Gil Gibli Where the Trump administration may be getting it right

Two documents reveal the difference between this US administration and its predecessor on Middle East policy.

Eli Tsipori  illustration: Gil Gibli An opportunity to break up Bezeq

The banks' move on Eurocom is meant to cover up for their sins, but there is a public interest that takes precedence over theirs.

Shiri Habib-Valdhorn  illustration: Gil Gibli Analysts reassess Teva

As Teva overtakes Check Point to regain the title of most valuable Israeli company, several analysts have revised previous pessimistic targets.

Shiri Habib-Valdhorn  illustration: Gil Gibli Will streamlining save Teva?

Financial measures may also be required to ensure Teva's survival.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018